Mini-chaperones

A CpG oligodeoxynucleotide potentiates the anti-tumor effect of HSP65-Her2 fusion protein against Her2 positive B16 melanoma in mice

(2012) Youyou Yan et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Immunomodulatory effects of IP-10 chemokine along with PEI600-Tat delivery system in DNA vaccination against HPV infections

(2012) Elham Mohit et al.   MOLECULAR IMMUNOLOGY

Cloning, expression, and immunogenicity of novel fusion protein of Mycobacterium tuberculosis based on ESAT-6 and truncated C-terminal fragment of HSP70

(2011) Majid Tebianian et al.   BIOLOGICALS

Comparison of adjuvant activity of N- and C-terminal domain of gp96 in a Her2-positive breast cancer model

(2011) Nafiseh Pakravan et al.   CELL STRESS & CHAPERONES

Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come

(2011) Ayesha Murshid et al.   Expert Review of Vaccines

Heat Shock Protein as Molecular Targets for Breast Cancer Therapeutics

(2011) Lee Su Kim et al.   Journal of Breast Cancer

Molecular chaperones in mammary cancer growth and breast tumor therapy

(2011) Stuart K. Calderwood et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

The Contribution of NT-gp96 as an Adjuvant for Increasing HPV16 E7-Specific Immunity in C57BL /6 Mouse Model

(2011) E. Mohit et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Immunization of protein HPV16 E7 in fusion with mouse HSP70 inhibits the growth of TC-1 cells in tumor bearing mice

(2011) Yan-Li Li et al.   VACCINE

Adjuvant activity of GP96 C-terminal domain towards Her2/neu DNA vaccine is fusion direction-dependent

(2010) Nafiseh Pakravan et al.   CELL STRESS & CHAPERONES

N-terminally fusion of Her2/neu to HSP70 decreases efficiency of Her2/neu DNA vaccine

(2010) Nafiseh Pakravan et al.   CELL STRESS & CHAPERONES

Co-administration of GP96 and Her2/neu DNA vaccine in a Her2 breast cancer model

(2010) Nafiseh Pakravan et al.   CELL STRESS & CHAPERONES

Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasis

(2010) Narges Abdian et al.   EXPERIMENTAL PARASITOLOGY

A novel vaccine strategy to induce mycobacterial antigen-specific Th1 responses by utilizing the C-terminal domain of heat shock protein 70

(2010) Tomohiro Uto et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Different spectra of therapeutic vaccine development against HPV infections

(2010) Azam Bolhassani et al.   Human vaccines & immunotherapeutics

GP96C-terminal improves Her2/neuDNA vaccine

(2010) Nafiseh Pakravan et al.   JOURNAL OF GENE MEDICINE

Dual Role of Heat Shock Proteins as Regulators of Apoptosis and Innate Immunity

(2010) Anne-Laure Joly et al.   Journal of Innate Immunity

Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47

(2010) M. P. Chao et al.   Science Translational Medicine

Heterologous expression, purification and characterization of the influenza A virus M2e gene fused to Mycobacterium tuberculosis HSP70359–610 in prokaryotic system as a fusion protein

(2009) Seyyed Mahmoud Ebrahimi et al.   MOLECULAR BIOLOGY REPORTS

Targeting the ubiquitin system in cancer therapy

(2009) Daniela Hoeller et al.   NATURE

Heat shock protein 70 (HSP70) induces cytotoxicity of T-helper cells

(2008) C. Figueiredo et al.   BLOOD

Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine

(2008) M. J.P. Welters et al.   CLINICAL CANCER RESEARCH

Heat-shock proteins as powerful weapons in vaccine development

(2008) Azam Bolhassani et al.   Expert Review of Vaccines

Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentation

(2008) M. K. Callahan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis

(2008) Bo Liu et al.   VACCINE

Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies

(2008) Azam Bolhassani et al.   VACCINE